Incidence of symptomatic Borrelia burgdorferi sensu lato infection in Romania, 2018−2023
There is a higher incidence of symptomatic Bbsl infection than is reported through public health surveillance for LB in Romania. Additional efforts are needed to strengthen disease prevention and address the important public health problem of LB.
Authors
- Mihaela Lupșe (ORCID: https://orcid.org/0000-0003-4010-2901)
- Frederick J. Angulo (ORCID: https://orcid.org/0000-0002-3120-7704)
- Patrick H. Kelly (ORCID: https://orcid.org/0000-0002-5155-6741)
- Violeta Briciu (ORCID: https://orcid.org/0000-0002-1229-4347)
- Kate Halsby
- Jennifer C. Moïsi (ORCID: https://orcid.org/0000-0002-7137-5630)
- James H. Stark (ORCID: https://orcid.org/0000-0002-0728-876X)
- Emily Colby
- Andreas Pilz (ORCID: https://orcid.org/0000-0002-6394-3845)
- Julia Olsen (ORCID: https://orcid.org/0000-0002-7781-4817)
- Adriana Hristea (ORCID: https://orcid.org/0000-0002-6505-1699)
- Gordon Brestrich (ORCID: https://orcid.org/0000-0002-1306-5474)
- Veronica Purdel
Institutions
- Carol Davila University of Medicine and Pharmacy (RO)
- Pfizer (United States) (US)
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- Veterans Health Administration (US)
- Petroleum & Gas University of Ploieşti (RO)
- Pfizer (Germany) (DE)
- Hologic (United States) (US)
- Global Vaccines (United States) (US)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Parasites & Vectors
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1186/s13071-024-06449-5
- Citations
- 4
- Primary Topic
- Vector-borne infectious diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.06
Funders
- Pfizer